Roundup, manufactured by Monsanto, is the most commonly used herbicide. It is used by agricultural professionals such as farmers, gardeners, maintenance workers, and many others as an all-purpose weed killer. Nearly 300 million pounds of Roundup are used on crops worldwide each year. For several decades, Monsanto has sold Roundup knowing that glyphosate causes cancer. Rather than warning consumers about cancer risks, Monsanto chose to secure the profit of Roundup’s sales. Today, Monsanto continues to deny claims that Roundup is carcinogenic, insisting that Roundup is safe. Past advertising for the herbicide included messaging that the product is “safer than table salt.”
REQUEST A FREE CONSULTATION
Get More Leads & Retainers With TSEG
In early 2015, IARC (International Agency for Research on Cancer) concluded Monsanto’s Roundup herbicide is “probably carcinogenic to humans.” The cancer most associated with exposure to glyphosate is non-Hodgkin lymphoma.
Symptoms of Non-Hodgkin Lymphoma:
- Swollen, painless, lymph nodes in groin, armpits, or neck
- Chest pain
- Difficulty breathing
- Coughing
- Abdominal pain/swelling
- Fatigue
- Sudden weightloss
- Night sweats
- Fever
Now Is the Time to Acquire Roundup Cases
- Lowest costs. Case costs in 2020 are the lowest we’ve seen.
- Reach a bigger audience. Stay-at-home conditions due to COVID-19 mean more people are watching TV and interacting with digital content. Now is an ideal time to reach your target audience.
- Costs to acquire cases have gone down. The increased viewership, in addition to reduced rates, bonus airings, and discounts, has led to reduced costs to get signed cases.
How TSEG Can Help
At TSEG, we manage lead-generation digital advertising campaigns to help your law firm on a wide array of platforms, including Google, Facebook, and Hulu. We will help you deliver your message about Roundup lawsuits to the potential clients and measure the return-data. The data that comes back from the ads is useful even if it does not convert to a lead. After we analyze the data, we will discover which copy, creative, and platform works best for your unique firm and message. We lever your advertising dollars in the most effective way possible, helping you to secure as many leads as you can. Our data-driven approach helps us deliver ½ to ⅓ the lead generation costs of our competitors.
In 2020, people are accustomed to the abundance of information on the internet, and they do plenty of research when deciding which firm to hire. Potential clients are no longer limited to the information that firms choose to advertise. Search engines are the tools used to seek out this information. Your firm’s search rankings will allow users to access key information like your location and customer reviews. A strong organic presence in search engines dramatically increases the chances people will pick your firm to take their Roundup case.
TSEG can also help you launch PPC, or Pay-Per-Click, campaigns. PPC helps you secure high placements on Google’s results page. PPC placements are at the top of the results page, above the maps and organic results. TSEG can help you optimize your PPC campaign so that you lower your costs while also reaching plenty of users.
Call us at (512) 894-8621 today
TSEG, a division of Cloud[8]Sixteen, Inc., has been providing SEO services for law firms since 2007. TSEG will work closely with you to effectively spotlight your firm through your digital marketing campaign. We’ll help you identify and sign emerging mass tort leads. Contact us online or call (512) 394-7234 to learn more.
Roundup Lawsuit Updates 2024
November 2024
November 15, 2024
In the Womack Roundup trial, the jury in the Philadelphia Court of Common Pleas reached a verdict siding with Monsanto. The win marks the company’s 15th favorable outcome in its last 22 trials. The case was a challenging one for the plaintiffs, as it concerned only ten residential uses of the Roundup since 2015.
November 1, 2024
The Roundup MDL (multidistrict litigation) has gained six new cases since October, bringing the total number of pending cases to 4,355. While new lawsuits continue to be filed in the MDL, Monsanto has also obtained settlement agreements in about 100,000 Roundup lawsuits (roughly two-thirds of all claims), paying out nearly $11 billion.
October 2024
A state court in Philadelphia awarded a total of $78 million in damages to William Melissen, who said his 2020 diagnosis of a blood cancer – Non-Hodgkin’s Lymphoma – was a result of over 30 years of Roundup use. Glyphosate, the active chemical in the pesticide, is said to be the main cause. Melissen was exposed to the Roundup pesticide from his use of it both at work and at home between 1992 and 2020. The lawsuit against Bayer and the verdict in the plaintiff’s favor resulted in $3 million in compensatory damages and $75 million in punitive damages.
September 2024
Roundup lawsuits took a couple of losses in September when the Third Circuit preserved federal preemption of stricter state labeling laws, putting a seal on Monsanto’s prior win. The court concluded that FIFRA preempts Pennsylvania’s laws on cancer warnings, preempting EPA-approved labels.
In Philadelphia, Monsanto won its Young v. Monsanto trial, as the jury decided there was no in-link between Roundup and non-Hodgkin lymphoma. In like fashion, an appeals panel in Missouri reaffirmed a trial court grant of summary judgment for Monsanto after excluding crucial expert testimony.
These results notwithstanding, plaintiffs’ overall record in trials in Philadelphia remains strong: $194.17 million average per verdict. There are 4,337 pending cases in this MDL.
August 2024
In the 3rd Circuit, Bayer had its most significant win when the court held that federal pesticide labeling regs preempt state laws. This verdict may significantly affect the Roundup trials, thereby restricting the labeling of cancer risks at the state level. Meanwhile, the 5th Philadelphia Roundup trial began, with plaintiffs hoping for their fourth consecutive victory out of five.
July 2024
The court’s July 8 order led to discussions on creating Wave 9 for the MDL, the final phase to handle remaining cases efficiently. The MDL, initiated in 2016, has resolved over 5,200 cases, with fewer than 500 active cases remaining. Plaintiffs’ counsel proposed switching to a mediation program for better negotiation flexibility. An Oregon appellate court overturned a previous decision to exclude expert testimony on EPA regulations, potentially impacting future cases.
June 2024
A judge in Philadelphia reduced the McKivison verdict from $2.25 billion to $400 million, maintaining significant litigation impact. The Roundup MDL saw a slight increase with six new cases, totaling 2,285. The focus remains on settlements and trial outcomes to pressure Bayer.
May 2024
Missouri legislation aimed at protecting Bayer from further lawsuits advanced but faced delays. A new lawsuit joined the MDL from a New York plaintiff diagnosed with non-Hodgkin lymphoma after prolonged Roundup use. The MDL saw a minor decrease, with three fewer cases, now totaling 4,279.
April 2024
Jury selection began in a St. Louis Roundup lawsuit filed by two women from Ohio and one from Oklahoma. Over 100 new Roundup cancer lawsuits were added to the MDL since the start of the year, with a total of 4,281 pending cases. Plaintiffs aim for a win to maintain pressure on Monsanto.
March 2024
Bayer secured a win with a Delaware mistrial, despite previous significant losses. Another Roundup trial in Arkansas concluded in Bayer’s favor. The MDL saw the largest monthly increase in new cases, now totaling 4,253. Monsanto petitioned the Eleventh Circuit to reconsider a ruling on a Georgia doctor’s claims.
February 2024
Roundup trials began in Pennsylvania and Arkansas, with another ongoing in Delaware. Monsanto sought immunity from pesticide-related lawsuits in state legislatures but failed. The MDL saw 26 new cases added, marking the largest monthly increase in six months, indicating ongoing litigation momentum.
January 2024
The Roundup MDL added three new cases, bringing the total to around 4,200. A significant verdict in McKivison resulted in a $2.25 billion award. Bloomberg highlighted Bayer’s need for a new strategy to handle Roundup litigation, emphasizing the necessity of increased settlement funds to avoid bankruptcy.
During our initial meeting, we’ll review your budget and any advertising campaigns you’re currently using. We can work on a plan that is cost-effective yet yields successful results.
We know the primary goal of any mass tort campaign is to turn leads into actual clients that sign with your law firm. You can count on the team at TSEG to help you accomplish that. For help with your mass tort campaign
Call us at (512) 394-7234
FREQUENTLY ASKED QUESTIONS
What is a multi-channel approach in mass tort marketing?
A multi-channel approach in mass tort marketing involves deploying campaigns across various platforms such as digital, social media, and traditional media to ensure comprehensive market coverage and maximum engagement. This method leverages different channels to meet potential clients where they are most likely to be receptive to your messaging.
